A population-based serosurvey in two rural Egyptian communities was used to
assess age-specific prevalence of antibody to hepatitis E virus (anti-HEV)
. One community is in the Nile Delta (11,182 inhabitants; 3,997 participant
s) and the other in Upper Egypt (10,970 inhabitants; 6,029 participants). S
amples were tested for anti-HEV with a commercial enzyme linked immunoassay
(ELISA) based on antigens derived from open reading frame (ORF)2 and ORF3.
Although there was a clear difference in sensitivity among the lots of the
commercial test used, it was still possible to determine the seroprevalenc
e. The seroprevalence of anti-HEV exceeded 60% in the first decade of life,
peaked at 76% in the second decade and remained above 60% until the eighth
decade. Prevalence of this magnitude is among the highest reported in the
world, with an age-specific pattern more similar to hyperendemic hepatitis
A virus transmission than generally described. Lot-to-lot variation in the
sensitivity of the commercial ELISA kit highlights a problem when comparing
seroepidemiologic studies of different populations.